Nebius Stock: Two Analyst Endorsements, a 50-Megawatt US Deal and the 193% Run Behind a $399 Target

Nebius shares closed at EUR 215.65, up 4.3%, as William Blair began coverage with an Outperform rating and BNP Paribas Exane raised its target to $399.

Nebius shares finished Friday's session at EUR 215.65, a gain of 4.3% that market watchers struggled to pin on any single company-specific headline. Instead, the advance rode a broader recovery in technology names after a softer-than-expected US jobs report for September eased rate concerns and handed growth stocks a fresh tailwind. Sentiment across the sector was further lifted by media reports that Broadcom could provide up to $60 billion in financing for chips designed by AI developer Anthropic, alongside speculation about price increases on Samsung's HBM memory products.

For investors trying to gauge how durable the revaluation of AI infrastructure specialists really is, the more telling signals this month have come from the analyst community rather than the tape.

William Blair Opens Coverage With an Outperform Rating

William Blair became the latest house to throw its weight behind the story, initiating coverage on Wednesday with an Outperform rating. Analyst Jason Ader pointed to the scaling of Nebius's infrastructure, its software capabilities, established customer relationships and access to fresh capital as the pillars of the call. The endorsement lands squarely in the middle of a shift in how the market judges companies in this space: pure software promises no longer suffice, and investors increasingly demand tangible evidence in the form of server capacity and network connectivity.

That same logic underpins the scale of the commitments Nebius is making. Securing physical infrastructure before competitors snap up available capacity has become a prerequisite for anyone hoping to compete in generative models, and the company's market capitalization of roughly EUR 56.08 billion reflects just how much the market now expects of it.

BNP Paribas Exane Lifts Its Target to $399

William Blair's entry followed a move earlier in the month from BNP Paribas Exane, which on September 24 upgraded the stock from Neutral to Outperform and raised its price target from $260 to $399. The convergence of bullish calls from multiple institutions has visibly strengthened institutional confidence in the business model, and the market is rewarding a company that benefits both from macroeconomic relief on rates and from the industry-wide wave of capital expenditure.

A 50-Megawatt Contract and an Inference Acquisition

The positive mood did not emerge from thin air. Nebius has been busy deepening its own value chain on two fronts. On Wednesday, AIB Data Centers disclosed a binding agreement to supply 50 megawatts of critical IT capacity to Nebius at a site in the southeastern United States. The contract runs for an initial term of twelve years, though financial terms were not made public — a silence that also surrounded the company's recent acquisition of inference specialist Inferize. That deal, whose price tag was likewise undisclosed, targets the production infrastructure of the Nebius Token Factory platform and addresses a central challenge in the industry: optimizing and efficiently running trained AI models once they are in operation.

Alongside these hardware and software moves, Nebius has been fine-tuning the cloud platform itself, adjusting usage-based pricing for graphics processors and rolling out improvements to network connectivity. The objective is straightforward — computing time should not merely be abundant, but processed and monetized more efficiently.

One disclosure that might raise eyebrows carries little strategic weight: director John Wilson Boynton IV sold 50 Class A shares at $235.01 on Tuesday under a Rule 10b5-1 trading plan established back on March 6, 2026. Given the minimal volume, the transaction has no bearing on the company's development.

Valuation Leaves Little Room for Error

Enthusiasm aside, the risks deserve a hearing. With the stock up 193% since the start of the year, it has already collected substantial advance praise, and a run of that magnitude naturally increases the downside if execution stumbles. Delays in bringing new sites online or unexpected cost inflation could cool the euphoria quickly.

Even so, the balance of arguments currently favors the bulls. Strategic repositioning, capacity locked in for the long term and growing attention from established research houses form a solid foundation. Should Nebius deliver on its platform scaling as planned, the present valuation may still fall well short of capturing the company's longer-term potential.